Is COVID-19 a New Contributing Factor to the Rise of Increasing Rectal Cancer Incidences in 2025 and 2026?
Nikhil Prasad Fact checked by:Thailand Medical News Team Aug 01, 2026 1 hour, 11 minutes ago
Alarming Rise in Rectal Cancer Among Younger Adults Sparks New Questions
Rectal cancer is emerging as one of the fastest-changing cancer trends in the United States, with health experts increasingly concerned that the disease is no longer confined to older populations. While established risk factors such as obesity, unhealthy diets, smoking, alcohol consumption, physical inactivity, inherited genetic syndromes, inflammatory bowel disease, and type 2 diabetes remain major contributors, scientists are now investigating whether previous SARS-CoV-2 infections could also be playing an indirect role in the growing burden of rectal cancer. This
Medical News report examines the latest evidence and why researchers are calling for deeper investigation rather than drawing premature conclusions.
Scientists are investigating whether persistent SARS-CoV-2 infection in the gut may contribute indirectly to the
rising incidence of rectal cancer among younger adults.
According to the American Cancer Society, an estimated 158,850 new colorectal cancer cases and approximately 55,230 deaths are expected in the United States in 2026. Nearly 45% of all new diagnoses now occur in adults younger than 65 years, compared to just 27% in 1995. Most strikingly, rectal cancer incidence has increased by about 1% annually since 2018 after decades of decline, fueled by a 3% yearly increase among adults aged 20 to 49 and a 0.4% annual rise among those aged 50 to 64. Rectal tumors now account for roughly 32% of all colorectal cancer cases, compared to only 27% in the mid-2000s.
Younger Patients Are Being Diagnosed at More Advanced Stages
Another troubling aspect of the trend is that younger adults are frequently diagnosed only after the disease has progressed. Current estimates suggest that three out of every four rectal cancer cases in individuals younger than 50 are detected at regional or distant stages, when treatment becomes more difficult and long-term survival rates decline. While delayed recognition of symptoms and reduced screening in younger adults remain major factors, researchers are searching for additional biological explanations behind the changing epidemiology.
Why SARS-CoV-2 Has Entered the Scientific Discussion
Scientists have become increasingly interested in the gastrointestinal effects of SARS-CoV-2 because the virus does not exclusively infect the lungs. Cells lining the colon and rectum express angiotensin-converting enzyme 2 (ACE2) receptors, the same cellular doorway the virus uses to enter human tissues. These epithelial cells throughout the lower gastrointestinal tract therefore remain biologically susceptible to viral infection.
Multiple laboratory studies have demonstrated that SARS-CoV-2 can infect intestinal cells, replicate within gastrointestinal tissues, and persist long after respiratory symptoms have resolved. Viral RNA has been detected in stool for weeks or even months after nasal swabs become negative, while biopsies have identified viral proteins and evidence of continued viral activity within glandular tissues of the colon and rectum.
>Persistent Gut Infection May Create Long-Term Biological Changes
Researchers believe persistent viral reservoirs within the gastrointestinal tract may contribute to chronic inflammation, disruption of the gut microbiome, and prolonged immune activation—features commonly associated with long COVID. Persistent infection appears capable of reducing beneficial intestinal bacteria while allowing potentially harmful microbial populations to expand, a condition known as dysbiosis.
Chronic inflammation has long been recognized as a factor capable of promoting DNA damage, abnormal cellular signaling, and changes in the local tissue environment that may favor cancer development. Scientists therefore hypothesize that prolonged SARS-CoV-2 persistence within colorectal tissues could theoretically influence pathways involved in tumor formation or progression. However, these mechanisms remain under active investigation and have not yet been proven to directly initiate rectal cancer.
Current Evidence Does Not Show COVID-19 Directly Causes Rectal Cancer
Despite growing scientific interest, researchers emphasize that there is currently no definitive clinical or epidemiological evidence proving that SARS-CoV-2 directly causes rectal cancer. Unlike viruses such as human papillomavirus (HPV), which are well-established cancer-causing viruses, SARS-CoV-2 is not classified as an oncogenic virus.
Instead, investigators are examining several indirect possibilities. Persistent intestinal inflammation, immune dysregulation, microbiome alterations, metabolic disturbances, and tissue remodeling following infection may potentially influence cancer risk in susceptible individuals. Separately, the COVID-19 pandemic caused widespread delays in colonoscopies, diagnostic testing, and routine healthcare, resulting in many colorectal cancers being detected at more advanced stages than would otherwise have occurred.
Traditional Risk Factors Still Dominate
Experts stress that established risk factors continue to account for the majority of rectal cancer cases. Excess body weight, diets rich in processed and red meats, inadequate fiber intake, smoking, excessive alcohol consumption, sedentary lifestyles, inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, family history, inherited syndromes including Lynch syndrome and familial adenomatous polyposis, previous colorectal polyps, and advancing age remain well-documented contributors.
Nevertheless, the rapid rise among younger adults who often lack several traditional risk factors has strengthened calls for expanded research into additional environmental, infectious, immunological, and metabolic influences that could be contributing to the changing disease landscape.
Growing Need for Long-Term Research
Large-scale longitudinal studies are now needed to determine whether individuals with persistent gastrointestinal SARS-CoV-2 infection experience altered colorectal cancer risks over time. Researchers are also investigating how viral persistence, chronic immune activation, microbiome disruption, and ACE2-related cellular changes interact with known genetic and lifestyle risk factors.
Understanding these complex relationships may eventually identify new prevention strategies, biomarkers, or therapeutic targets while improving cancer surveillance among higher-risk populations.
Although the current evidence does not support claims that COVID-19 directly causes rectal cancer, it does provide compelling biological reasons for continued investigation. Given the sustained increase in rectal cancer among younger adults, the demonstrated persistence of SARS-CoV-2 within the intestinal and rectal tissues, and the virus's ability to alter immune and microbial environments and cause continuous low and mid-grade inflammation, researchers believe these potential connections deserve careful scientific evaluation rather than dismissal. Clarifying whether COVID-19 contributes indirectly to cancer development could significantly influence future screening recommendations, long COVID management, and preventive public health strategies.
References:
https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.70067
https://ecancer.org/en/news/28128-rectal-cancer-is-striking-earlier-and-killing-faster
https://pressroom.cancer.org/rectal-cancer-incidence-rising
https://atm.amegroups.org/article/view/49436/html
https://www.sciencedirect.com/science/article/pii/S2590053621000860
https://atm.amegroups.org/article/view/39648/html
https://www.mdpi.com/2072-6694/13/11/2676
https://europepmc.org/article/ppr/ppr114297
https://linkinghub.elsevier.com/retrieve/pii/S0016508522004504
https://www.mdpi.com/1999-4915/18/2/247
https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-2180-9872
https://academic.oup.com/cid/article/73/3/361/5868547
https://www.wjgnet.com/1007-9327/full/v27/i14/1406.htm
https://www.sciencedirect.com/science/article/pii/S1876034120304913
https://www.sciencedirect.com/science/article/pii/S1043466622000357
https://www.sciencedirect.com/science/article/pii/S1043466622000357
https://www.moffitt.org/cancers/rectal-cancer/diagnosis/risk-factors/
https://www.nature.com/articles/s41598-024-75718-1
https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.33217
Read Also:
https://www.thailandmedical.news/articles/coronavirus
https://www.thailandmedical.news/articles/long-covid
Share
Tweet
Share
